The advent of the COVID-19 rapid antigen test launched at-home diagnostics to the forefront of conversation in the life sciences industry. Many believe this is only the beginning. As the share of telehealth services...more
The advent of the COVID-19 rapid antigen test launched at-home diagnostics to the forefront of conversation in the life sciences industry. Many believe this is only the beginning. As the share of telehealth services...more
3/29/2024
/ Contract Modification ,
Coronavirus/COVID-19 ,
Diagnostic Tests ,
Force Majeure Clause ,
Healthcare ,
Intellectual Property Protection ,
Inventions ,
Life Sciences ,
Limitation of Liability Clause ,
Patents ,
Telehealth ,
Virus Testing
The advent of the COVID-19 rapid antigen test launched at-home diagnostics to the forefront of conversation in the life sciences industry. Many believe this is only the beginning. As the share of telehealth services...more
3/25/2024
/ Coronavirus/COVID-19 ,
Diagnostic Tests ,
Disclaimers ,
Exit Strategies ,
Indemnification ,
Intellectual Property Protection ,
Limitation of Liability Clause ,
Privacy Policy ,
Shareholders ,
Software ,
Uniform Commercial Code (UCC) ,
Virus Testing
For in vitro diagnostic test developers, the monkeypox public health emergency presents an urgent public health need for testing as well as a unique opportunity for rapid regulatory review of testing products....more